Takeda Pharmaceutical Shares Outstanding 2007-2020 | TAK

Takeda Pharmaceutical shares outstanding history from 2007 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Takeda Pharmaceutical shares outstanding for the quarter ending September 30, 2020 were 3.146B, a 0.7% increase year-over-year.
  • Takeda Pharmaceutical 2020 shares outstanding were 3.132B, a 61.98% increase from 2019.
  • Takeda Pharmaceutical 2019 shares outstanding were 1.934B, a 22.9% increase from 2018.
  • Takeda Pharmaceutical 2018 shares outstanding were 1.573B, a 0.1% increase from 2017.
Takeda Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2020 3,132
2019 1,934
2018 1,573
2017 1,572
2016 1,576
2015 1,573
2014 1,581
2013 1,579
2012 1,579
2011 1,579
2010 1,579
2009 1,617
2008 1,697
2007 1,740
2006 1,772
Takeda Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 3,146
2020-06-30 3,118
2020-03-31 3,132
2019-12-31 3,115
2019-09-30 3,124
2019-06-30 3,111
2018-12-31 1,573
2018-06-30 1,564
2017-06-30 1,560
2016-06-30 1,564
2015-06-30 1,570
2015-03-31 1,574
2014-12-31 1,578
2014-09-30 1,572
2014-06-30 1,575
2014-03-31 1,578
2013-12-31 1,581
2013-09-30 1,578
2013-06-30 1,581
2013-03-31 1,580
2012-12-31 1,579
2012-09-30 1,579
2012-06-30 1,579
2012-03-31 1,579
2011-12-31 1,578
2011-09-30 1,582
2011-03-31 1,579
2010-03-31 1,579
2009-09-30 6
2009-03-31 1,588
2008-03-31 1,940
2007-03-31 1,716
2006-03-31 1,790
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $54.984B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.784B 41.85
Astellas Pharma (ALPMY) Japan $29.565B 18.47
Merck (MKGAF) Germany $22.940B 0.00
Eisai (ESALY) Japan $22.210B 19.35
UCB SA (UCBJF) Belgium $20.583B 0.00
Catalent (CTLT) United States $19.023B 56.90
Grifols, S.A (GRFS) Spain $13.118B 15.02
Neurocrine Biosciences (NBIX) United States $10.061B 79.18
Jazz Pharmaceuticals (JAZZ) Ireland $9.344B 15.10
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.578B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 83.94
Arrowhead Pharmaceuticals (ARWR) United States $8.297B 0.00
United Therapeutics (UTHR) United States $7.680B 16.35
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.819B 394.44
Sage Therapeutics (SAGE) United States $4.756B 0.00
PTC Therapeutics (PTCT) United States $4.673B 0.00
Hypermarcas (HYPMY) Brazil $4.415B 17.42
ChemoCentryx (CCXI) United States $4.292B 0.00
FibroGen (FGEN) United States $3.934B 0.00
Cronos Group (CRON) Canada $3.889B 0.00
Corcept Therapeutics (CORT) United States $3.269B 31.62
Pacira BioSciences (PCRX) United States $3.201B 69.51
Nektar Therapeutics (NKTR) United States $3.046B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.972B 15.17
Xencor (XNCR) United States $2.784B 0.00
Revolution Medicines (RVMD) United States $2.706B 0.00
Tilray (TLRY) Canada $2.630B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.766B 15.11
Translate Bio (TBIO) United States $1.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.685B 0.00
USANA Health Sciences (USNA) United States $1.669B 14.69
Endo (ENDP) Ireland $1.640B 2.49
Heron Therapeutics (HRTX) United States $1.603B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.554B 0.00
Ocular Therapeutix (OCUL) United States $1.542B 0.00
Trillium Therapeutics (TRIL) Canada $1.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
ImmunoGen (IMGN) United States $1.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.151B 0.00
Indivior (INVVY) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.038B 0.00
ORGANOGENESIS (ORGO) United States $1.024B 0.00
Radius Health (RDUS) United States $1.012B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.938B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
VAXART, INC (VXRT) United States $0.786B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.721B 0.00
Esperion Therapeutics (ESPR) United States $0.712B 0.00
Acutus Medical (AFIB) United States $0.659B 0.00
Aerie Pharmaceuticals (AERI) United States $0.653B 0.00
Flexion Therapeutics (FLXN) United States $0.644B 0.00
Chinook Therapeutics (KDNY) United States $0.641B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Harpoon Therapeutics (HARP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.563B 15.80
Molecular Templates (MTEM) United States $0.552B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.524B 0.00
Sundial Growers (SNDL) Canada $0.504B 0.00
PROFOUND MEDICL (PROF) Canada $0.491B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Summit Therapeutics (SMMT) United States $0.438B 0.00
Altimmune (ALT) United States $0.428B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
TherapeuticsMD (TXMD) United States $0.414B 0.00
DURECT (DRRX) United States $0.412B 0.00
Rafael Holdings (RFL) United States $0.400B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Jounce Therapeutics (JNCE) United States $0.363B 0.00
Concert Pharmaceuticals (CNCE) United States $0.363B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.362B 9.43
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
MEI Pharma (MEIP) United States $0.320B 0.00
Alpine Immune Sciences (ALPN) United States $0.313B 0.00
KalVista Pharmaceuticals (KALV) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.304B 19.59
Menlo Therapeutics (VYNE) United States $0.280B 0.00
Lannett Co Inc (LCI) United States $0.279B 7.36
Redhill Biopharma (RDHL) Israel $0.278B 0.00
Jaguar Animal Health (JAGX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.263B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
Otonomy (OTIC) United States $0.251B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.237B 0.00
Calithera Biosciences (CALA) United States $0.235B 0.00
OptiNose (OPTN) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.209B 0.00
Infinity Pharmaceuticals (INFI) United States $0.204B 0.00
ProPhase Labs (PRPH) United States $0.194B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.188B 0.00
Novan (NOVN) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
IsoRay (ISR) United States $0.173B 0.00
Onconova Therapeutics (ONTX) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.166B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.165B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Heat Biologics (HTBX) United States $0.145B 0.00
MediWound (MDWD) Israel $0.137B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.113B 0.00
Lipocine (LPCN) United States $0.106B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.082B 158.75
ElectroCore (ECOR) United States $0.080B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
Recro Pharma (REPH) United States $0.070B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.070B 0.00
AgeX Therapeutics (AGE) United States $0.069B 0.00
Biomerica (BMRA) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
Vical (BBI) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.059B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 24.96
Regulus Therapeutics (RGLS) United States $0.047B 0.00
PolarityTE (PTE) United States $0.042B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.56
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00